Zobrazeno 1 - 10
of 16
pro vyhledávání: '"A D, Shirin"'
Autor:
Yu. E. Ryabukhina, A. D. Shirin, O. L. Timofeeva, N. N. Tupitsyn, M. A. Frenkel, N. A. Kupryshina, M. A. Volkova
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 31-37 (2022)
Between July 2005and October 2006, eight patients (pts) with hairy cell leukaemia were treated with Vero- cladribine at N.N. Blokhin Cancer Research Center. All pts achieved complete remission (CR). Duration of CR ranges from 1+ to 12+ months in 7 ca
Externí odkaz:
https://doaj.org/article/9d9cb8e84d6349099381d81d3d645393
Publikováno v:
Russian Journal of Biotherapy. 22:10-18
Cancer-testis antigens (CTA) are antigens expressed by tumor cells of various histological types, but practically absent in cells of normal tissues, with the exception of germ cells. CTA includes more than 100 proteins, most of which are grouped into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d78d2a831e0217cbfa75fe2592f95d26
https://doi.org/10.17650/1726-9784-2023-22-1-10-18
https://doi.org/10.17650/1726-9784-2023-22-1-10-18
Autor:
A. D. Shirin, R. Ya. Vlasenko, N. Yu. Anisimova, K. I. Kirgizov, T. T. Valiev, N. G. Stepanyan, T. Z. Aliev, G. E. Morozevich, O. A. Odaryuk, D. V. Filonenko, N. E. Nifantiev, K. M. Novruzov, I. O. Chikileva, M. V. Kiselevskiy
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:64-74
Conditioning regimens prior to hematopoietic stem cell transplantation (HSCT) are often accompanied by a period of aplasia characterized by severe neutropenia, anemia, and thrombocytopenia. Long-term antibacterial and immunosuppressive therapy in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5445c331ccb2a34270fca71863c5554c
https://doi.org/10.21682/2311-1267-2022-9-4-64-74
https://doi.org/10.21682/2311-1267-2022-9-4-64-74
Autor:
A. A. Solodovnik, H. S. Mkrtchyan, V. A. Misyurin, V. V. Tikhonova, Yu. P. Finashutina, N. N. Kasatkina, O. N. Solopova, O. M. Votyakova, O. Yu. Yakimovich, O. M. Volodina, M. Yu. Kichigina, E. G. Medvedovskaya, A. S. Antipova, I. Z. Zavodnova, A. A. Semenova, G. R. Arakelyan, Yu. E. Ryabukhina, O. A. Kolomeytsev, A. D. Shirin, E. A. Osmanov, A. V. Misyurin
Publikováno v:
Успехи молекулярной онкологии, Vol 5, Iss 2, Pp 62-70 (2018)
Objective: to study the prognostic significance of the expression of cancer-testis (CT) genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 in patients with multiple myeloma (MM) and their influence on overall survival and rel
Externí odkaz:
https://doaj.org/article/b0aa8abe11aa425e8a24ca45472d22ad
Autor:
Ol'ga Yur'evna Baranova, Anton Dmitrievich Shirin, Natal'ya Aleksandrovna Falaleeva, Evgeniy Aleksandrovich Osmanov, O Yu Baranova, A D Shirin, N A Falaleeva, D Sh Osmanov
Publikováno v:
Терапевтический архив, Vol 83, Iss 7, Pp 26-32 (2011)
We report a case of aceptic osteonecrosis (AON) of the left hymerus epiphysis in programmed treatment of a male patient with lymphoblastic lymphoma to illustrate clinical, laboratory, epidemiological, pathogenetic, diagnostic and therapeutic aspects
Externí odkaz:
https://doaj.org/article/1c0816b7152a4fbeb8a6b623b09b88dd
Autor:
E A Osmanov, I V Podtsubnaya, M A Volkova, E A Demina, G S Tumyan, O M Votyakova, A D Shirin, V B Larionova, E N Sorokin
Publikováno v:
Современная онкология, Vol 9, Iss 4, Pp 27-35 (2007)
Институт экспериментальной и клинической онкологии РАМН (ИЭиКО) существовал уже более 10 лет, интенсивно развивался, реализовались разн
Externí odkaz:
https://doaj.org/article/940d51a07a884b2ca353c74a7957723d
Autor:
I V Poddubnaya, D Sh Osmanov, N A Probatova, N N Tupitsin, G V Kruglova, A Ya Kuril'nikov, E N Sholokhova, L V Manzyuk, A G Borodkina, A D Shirin, E N Unukova, P A Zeynalova, T E Byalik, E N Sorokin, O A Petrov
Publikováno v:
Современная онкология, Vol 3, Iss 2, Pp 57-60 (2001)
В России использование препарата "Мабтера" было начато в сентябре 1999 г. в соответствие с многоцентровым российским открытым нерандомизи
Externí odkaz:
https://doaj.org/article/70c5325e5631423380ac90293970ac7c
Publikováno v:
Современная онкология, Vol 3, Iss 2, Pp 52-55 (2001)
Острый промиелоцитарный лейкоз - ОПЛ (МЗ по FAB-классификации) - довольно редкий вариант острого лейкоза, на его долю приходится не более 10%
Externí odkaz:
https://doaj.org/article/e93fc35a2085470895003634f41dd97d
Autor:
G. R. Arakelyan, O. Yu. Yakimovich, Yu. P. Finashutina, NN Kasatkina, A. S. Antipova, Yu. E. Ryabukhina, V. A. Misyurin, H. S. Mkrtchyan, A. A. Semenova, A D Shirin, M. Yu. Kichigina, IZ Zavodnova, A. A. Solodovnik, O. M. Votyakova, O. A. Kolomeytsev, V. V. Tikhonova, A. V. Misyurin, O. N. Solopova, EG Medvedovskaya, EA Osmanov, O. M. Volodina
Publikováno v:
Uspehi Molekulârnoj Onkologii, Vol 5, Iss 2, Pp 62-70 (2018)
Objective:to study the prognostic significance of the expression of cancer-testis (CT) genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 in patients with multiple myeloma (MM) and their influence on overall survival and rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137a3d13249c8ed9ac972e7a59885eb6
https://doi.org/10.17650/2313-805x-2018-5-2-62-70
https://doi.org/10.17650/2313-805x-2018-5-2-62-70
Publikováno v:
IJCNN
This paper presents an evolving spiking neural network namely, `Basis Coupled Evolving Spiking Neural Network (BCESNN)' and its learning algorithm to solve real-valued pattern recognition problems. BCESNN is a two-layered neuron model with afferent n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::737d72f79b3e3c859f777661b8e39ecb
https://doi.org/10.1109/ijcnn.2013.6706964
https://doi.org/10.1109/ijcnn.2013.6706964